National Cancer Screen LLC is a post-development research lab based in Chesterfield, MO, dedicated to revolutionizing healthcare through advanced proteomic diagnostics for early cancer detection and monitoring. Their mission is to provide accessible and reliable universal cancer screening through a game-changing blood test that can detect problems before symptoms occur, leading to more effective treatment and improved health outcomes.
With over 27 years of expertise, National Cancer Screen LLC leverages affordable and advanced proteomic diagnostic technologies, utilizing a single common marker called MPS-1, to make early-stage, blood-based cancer detection and monitoring a routine procedure in standard medical care. Their approach aims to reduce the cost of care, empower better health, and increase longevity by detecting cancer at its earliest stages.
Generated from the website